https://beta.cnbctv18.com/earnings/divis-labs-q1-results-share-price-revenue-drops-profit-nearly-halves-molnupiravir-margin-17523811.htm
Divi's Labs Q1 Results: Management sees multiple growth prospects in next three years, price pressure stabilising